Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
First Claim
Patent Images
28-1. Use of a pharmaceutical aerosol formulation according to any one of claims 1 to 31 in the manufacture of a medicament for the treatment of respiratory disorders, eg. asthma or chronic obstructive pulmonary disease (COPD).
2 Assignments
0 Petitions
Accused Products
Abstract
There is provided according to the invention a pharmaceutical aerosol formulation which comprises: (i) salmeterol or a pharmaceutically acceptable salt thereof, (ii) fluticasone propionate and (iii) a hydrofluoroalkane (HFA) propellant, characterized in that the salmeterol or pharmaceutically acceptable salt thereof and fluticasone propionate are completely dissolved in the formulation.
-
Citations
34 Claims
-
28-1. Use of a pharmaceutical aerosol formulation according to any one of claims 1 to 31 in the manufacture of a medicament for the treatment of respiratory disorders, eg. asthma or chronic obstructive pulmonary disease (COPD).
Specification